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Factors associated with study completion in younger adults are not well understood. This
study sought to describe psychosocial, clinical, and demographic features associated with
completion of a study of men and women with premature acute coronary syndrome.
Methods
As part of the GENdEr and Sex determInantS of cardiovascular disease: From bench to
beyond-Premature Acute Coronary Syndrome (GENESIS-PRAXY) study, demographic,
psychosocial, and clinical variables were assessed in 1213 patients hospitalized for acute
coronary syndrome ( 55 years; 30% women). Patients were followed for 12 months. Drop-
outs withdrew from the study or were lost to follow-up after 12 months; completers were still
enrolled after 12 months.
Results
Of 1213 patients initially enrolled, 777 (64.1%) completed 12-month follow-up. Fully
adjusted models suggested that being older (OR = 1.04, 95% CI [1.01, 1.06]), higher subjec-
tive social status within one’s country (OR = 1.11, 95% CI [1.01, 1.22]), being free of type II
diabetes, (OR = 0.66, 95% CI [0.45, 0.97]), non-smoking status (OR = 0.70, 95% CI [0.51,
0.95]) and being free of depression (OR = 1.52, 95% CI [1.11, 2.07]) were independently
associated with study completion.
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Conclusions
Recruitment/retention strategies targeting individuals who smoke, are younger, have low
subjective social status within one’s country, have diabetes, or have depression may
improve participant follow-up in cardiovascular cohort studies.
Introduction
Ensuring participation and retention of subjects in cohort studies remains a challenge, as rates
of attrition in cohort studies have increased over the past several decades [1–3]. When data are
missing completely at random, measures of association and inferences drawn from the results
are typically valid. However, attrition is rarely a completely random event in cohort studies
[4]. More likely the case, those who complete cohort studies (“completers”) differ systemati-
cally from those who are lost to follow up (“dropouts”), which in turn reduces the reliability
and generalizability of the results and lowers statistical power [4–6].
In general, several factors have univariate associations with not completing longitudinal
health studies, including being older, being cognitively impaired, increasingly ill health, liv-
ing alone, not being married, lower socio-economic status (SES), less social activity, and obe-
sity. Conversely, being retired and having more living children are associated with greater
study completion [7, 8]. However, only increasing age and cognitive impairment seem to be
independently associated with not completing longitudinal studies [8]. Moreover, few studies
have examined whether completers and dropouts differ systematically in cohorts of cardio-
vascular patients or cardiovascular prevention [9–11]. In these studies, study completion was
associated with several sociodemographic (i.e., higher income, lower body mass index (BMI),
older age, female sex, and white ethnicity), access-to-care (i.e., attendance of health fairs and
having health insurance), clinical (i.e., not smoking, having metabolic syndrome and hyper-
tension, lower HDL cholesterol level, and adherence to cardiac medication), and psychoso-
cial (i.e., lower levels of depression, anxiety, and general stress) characteristics [9–11]. These
studies, however, had important limitations. For instance, one study only reported unad-
justed results [9] whereas another did not examine men or report their female participants’
age [11]. Moreover, the two studies that did report age [9, 10] only examined older adults
(i.e., greater than 59 years). However, no known study has examined predictors of study com-
pletion in younger patients with premature acute coronary syndrome (ACS). It is important
to examine such younger individuals because they likely have a different life situation than
older adults, e.g., work, child rearing, and income, and these factors may influence study
completion differently.
Identifying factors associated with study completion in cardiovascular cohorts is a step
toward developing and/or improving recruitment and retention strategies. Therefore, the pur-
pose of this study was to identify factors associated with completion of a longitudinal study of
patients with premature ACS.
Materials and methods
Study design and protocol
We report a sub-analysis of the GENdEr and Sex determInantS of cardiovascular disease:
from bench to beyond—PRemature Acute Coronary SYndrome (GENESIS-PRAXY) study.
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This is a prospective, multicenter study with a 12-month follow-up of patients with prema-
ture ACS. Patients were recruited from 24 centers in Canada, one in Switzerland, and one in
the United States, from January 2009 to April 2013. A research nurse contacted the patients
by telephone at 1, 6, and 12 months. At these times, the nurse validated the participants’
addresses and then mailed them questionnaires to complete and return. Full details of the
methods have been explained previously [12]. Approval of the study was obtained from all
sites from their respective ethics review boards. Overall approval of the study was granted
by the University of British Columbia Providence Health Care Research Institute (Reference
number: PHC REB H08-01382). Additionally, ethics approval was received from the ethics
committees of the following institutions: St Paul’s Hospital, Vancouver, British Columbia,
Canada; Surrey Memorial Hospital, Surrey, British Columbia, Canada; Libin Cardiovascular
Institute of Alberta, University of Calgary, Calgary, Alberta, Canada; University of Alberta
and the Mazankowski Alberta Heart Institute, Edmonton, Alberta, Canada; University of
Ottawa Heart Institute, Ottawa, Ontario, Canada; McMaster University/Hamilton Health
Sciences (General Site), Hamilton, Ontario, Canada; McMaster University/Hamilton Health
Sciences (Juravinski Site), Hamilton, Ontario, Canada; Ottawa Hospital, Ottawa, Ontario,
Canada; St Michael’s Hospital, Toronto, Ontario, Canada; London Health Sciences Centre,
London, Ontario, Canada; The Scarborough Hospital, General Division, Scarborough,
Ontario, Canada; Hôpital Général de Montréal, Montréal, Québec, Canada; Hôpital Royal
Victoria, Montréal, Québec, Canada; Hôpital Général Juif-Sir Mortimer B. Davis, Montréal,
Québec, Canada; Institut universitaire de cardiologie et de pneumologie de Québec (Hôpital
Laval), Québec, Québec, Canada; Hôpital du Sacré-Coeur de Montréal, Montréal, Québec,
Canada; Cité de la Santé de Laval, Laval, Québec, Canada; Hôtel Dieu du Centre Hospitalier
de l’Université de Montréal, Montréal, Québec, Canada; Centre de santé et de services
sociaux de la région de Thetford, Thetford Mines, Québec, Canada; CSSS Chicoutimi, Chi-
coutimi, Québec, Canada; Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke,
Québec, Canada; CSSS Alphonse Desjardins (CHAU—Hôtel-Dieu de Lévis), Lévis, Québec,
Canada; Queen Elizabeth II Health Science Centre, Halifax, Nova Scotia, Canada; The New
Brunswick Heart Centre Research Initiative and The New Brunswick Heart Centre, New
Brunswick, Canada; Basset Healthcare, Cooperstown, New York, USA; Inselspital, Univer-
sity of Bern, Switzerland and Lausanne University Hospital, Lausanne, Switzerland.
Written informed consent was obtained from all participants and the study was carried out
in accordance with the Declaration of Helsinki.
Study completion
To augment completion of questionnaires at each follow-up, the following procedure was per-
formed: 1) A research nurse called the patient a few days before the date of the follow-up to
ensure the patient’s address was correct and to remind the patient that they will receive a ques-
tionnaire by mail, which they will need to complete and return in the stamped envelope. 2)
Once the address was confirmed, the nurse sent the questionnaire by mail. 3) If the address
could not be confirmed, the nurse would send the questionnaire to the address indicated in
the patient’s file. 4) If the questionnaire was not received within a few weeks, the nurse
repeated steps 1–3 up to two additional times. 5) If preferred, participants could complete the
questionnaire over the phone. This occurred only in 8 patients. 6) If questionnaires were
received at all three follow-ups, participants received a $20 gift certificate.
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Participants who could not be contacted or did not return the questionnaires at 12 months
for any reason other than death were classified as dropouts. Those who completed the ques-
tionnaires at 12 months were classified as completers.
Study population and data sources
Patients presenting to a participating hospital with ACS who were between 18 and 55 years
old, fluent in French or English, and capable of giving informed consent were eligible. A
research nurse approached each eligible patient in the coronary care unit as soon as possible
after hospital admission. A total of 1213 patients were recruited.
Potential factors associated with study completion
Based on previous research [7–11], several characteristics were identified as potential factors
associated with study completion. Medication use at time of hospitalization (i.e., Calcium
antagonists, ACE inhibitors, and statins), number of medications at time of discharge, previ-
ous diagnosis of dyslipidemia, hypertension, and diabetes were determined from chart review.
Body mass index was calculated from height and weight. From self-report data, age, sex, eth-
nicity, education level, work status, job satisfaction, income, smoking status, availability of
health insurance, access to health care, satisfaction with health care, stress at work, stress at
home, and overall stress level were determined. “Satisfaction with health care” variables were
assessed with one question each. Availability of health care was assessed with the question
“Overall, how would you rate the availability of health care services in your area?” Quality of
health care was assessed with the question “Overall, how would you rate the quality of the
health care services that are available in your area?” Participants answered these two questions
on a 1–4 scale with 1 = Poor and 4 = Excellent. Satisfaction with treatment was assessed with
the question “Overall, how satisfied are you with the treatment that you received, over the past
12 months?” Participants answered this question on a 1–5 scale with 1 = not satisfied at all and
5 = very satisfied. Stress at work, stress at home, and overall stress level were measured on a
scale from 1 (no stress) to 10 (most stress).
Based on items in our questionnaire, major depression was assessed using the Diagnostic
and Statistical Manual of Mental Disorders, 4th edition criteria [13]. Specifically, participants
were asked to think about how they felt prior to their ACS and answer nine questions repre-
senting DSM-IV criteria for major depression. Major depression was subsequently identified if
five or more of the nine questions were answered “yes” and if one of the symptoms was either
a loss of interest in daily activities or feeling blue sad, or depressed most days of the week for
two weeks or more in a row [13]. Symptoms of depression and anxiety were also assessed with
the Hospital Anxiety and Depression Scale [14].
Traits of personality traditionally ascribed to men and women were assessed with the Bem
Sex Role Inventory [15], which produces independent scores of “femininity” and “masculin-
ity”. Based on gender stereotypes, it measures the extent to which a person identifies as fitting
into traditional sex roles. A high masculinity score does not necessarily indicate a low feminin-
ity score, and vice versa, because masculinity scores and femininity scores are mutually exclu-
sive. Subjective social status within one’s community and within one’s country was assessed
with the MacArthur Subjective Social Status Scale (MSSS) [16]. Independent of objective mea-
sures of socioeconomic status like income and education, the MSSS aims to denote respon-
dents’ view of where they stand in society, considering multiple dimensions of socioeconomic
status and social position. For income, we compared those who reported being below low-
income cutoffs to those above the cutoffs, based on Stats Canada figures [17]. Specifically, we
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compared those who reported personal income to be $22,500 or less to those who reported
making more than $22,500.
Statistical analyses
Baseline characteristics were compared between the completers and dropouts. Continuous
variables were compared using t-tests or Wilcoxon tests, whereas categorical variables were
compared using χ2 tests. Those variables in which completers and dropouts differed statisti-
cally significantly were further included in a stepwise manner in four multivariable logistic
regression models. For these models, BMI was examined as not obese (BMI< 30) versus obese
(BMI 30). The first model included sociodemographic variables. The second model included
sociodemographic and access to care variables. The third model included sociodemographic,
access-to-care, and clinical variables. The fourth model included sociodemographic, access to
care, clinical, and psychosocial variables. All analyses were performed using SAS statistical
package version 9.2 (Cary, North Carolina). Two-tailed p-values < .05 were considered
significant.
Results
Participant characteristics and univariate analyses
Of the 1213 patients initially enrolled, 777 (64.1%) completed the study through 12 months fol-
low-up. In comparison to those in the dropouts group, those in the completers group were
older, had a lower Bem masculinity score, greater subjective social status within their commu-
nity and within their country, and greater satisfaction with availability of health care. More-
over, completers were more likely to be white compared to other ethnicities, be working, be
over the poverty line, have a diploma or degree, have a family doctor, be nonsmokers, not have
type II diabetes, not have major depression and report experiencing more stress at work
(Table 1).
Multivariate analyses
Variables having univariate associations with study completion were included in the multivari-
ate analyses (Fig 1). In the first logistic regression model including sociodemographic vari-
ables, older age (OR = 1.04, 95% CI [1.01, 1.06]), a lower BEM masculinity score (OR = 0.83,
95% CI [0.70, 0.97]), having a diploma or degree (OR = 1.41, 95% CI [1.05, 1.91]), and higher
subjective social status within one’s country (OR = 1.16, 95% CI [1.05, 1.27]) were associated
with greater odds of study completion. When adding access to care variables in the second
model, older age (OR = 1.03, 95% CI [1.01, 1.06]), lower BEM masculinity score (OR = .84,
95% CI [.71, .98]), having a diploma or degree (OR = 1.39, 95% CI [1.03, 1.88]) and higher sub-
jective social status within one’s country (OR = 1.14, 95% CI [1.04, 1.25] were still associated
with greater odds of study completion, whereas access to care variables were not.
When adding clinical characteristics in the third model, older age (OR = 1.04, 95% CI [1.01,
1.06]), and higher subjective social status within one’s country (OR = 1.11, 95% CI [1.01,
1.22]) remained associated with greater odds of study completion, as was being a nonsmoker
(OR = 0.67, 95% CI [0.49, 0.91], and not having Type II diabetes (OR = 0.65, 95% CI [0.44,
0.96]). Education was no longer associated with greater odds of study completion. When
including psychosocial variables in the fourth and fully adjusted model, older age (OR = 1.04,
95% CI [1.01, 1.06]), higher subjective social status within one’s country (OR = 1.11, 95% CI
[1.01, 1.22], not smoking (OR = 0.70, 95% CI [0.51, 0.95]), not having type II diabetes,
Study completion in premature acute coronary syndrome patients
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Table 1. Sociodemographic, clinical, access to care, and psychosocial characteristics by categories of 12-month retention.
Dropouts group Completers group p
Sociodemographic variables n Mean/Median n Mean/Median
Age (yrs), median (IQR) 433 49 (8.00) 773 50 (7.00) .0351*
Sex, n (% female) 435 139 (31.95) 777 253 (32.56) .8284
Bem score, mean (SD)
Femininity score 374 5.71 (0.98) 756 5.63 (0.91) .1653
Masculinity score 375 5.06 (0.94) 755 4.93 (0.91) .0301*
Ethnicity, n (% not white) 435 99 (22.81) 777 107 (13.77) < .0001Ψ
Subjective Social Status, mean (SD)
In the community 358 5.74 (2.07) 745 6.06 (1.96) .0129*
In one’s country 358 5.10 (2.14) 742 5.67 (2.05) < .0001Ψ
Currently working, n (%) 435 291 (66.89) 777 612 (78.76) < .0001Ψ
Job Satisfaction, mean (SD) 307 62.36 (15.00) 641 62.78 (13.89) .6749
Personal annual income, n (% < $22,500) 317 135 (42.59) 651 207 (31.8) .001**
Education, n (% with post-secondary degree) 328 83 (25.30) 663 260 (39.22) < .0001Ψ
Access to Care variables
Receive supplementary medical benefits, n (%) 262 204 (77.86) 613 478 (77.98) .9701
Have a family doctor, n (%) 375 297 (79.20) 761 646 (84.89) .0164*
Difficulty getting routine health care, n (%) 359 73 (20.33) 709 140 (19.75) .8202
Difficulty getting specialist health care, n (%) 284 48 (16.90) 584 86 (14.73) .4053
Satisfaction with health services, mean (SD)
Availability of health care 368 2.16 (0.96) 748 1.99 (0.86) .0025**
Quality of health care 367 1.93 (0.87) 743 1.86 (0.81) .1533
Satisfaction with treatment 351 3.96 (1.06) 738 4.07 (1.01) .0897
Clinical Characteristics
Smoking, n (%) 434 187 (43.09) 777 275 (35.39) .0082**
Taking Cardiovascular Medications at time of hospitalization, n (%)
Calcium antagonists 434 27 (6.22) 777 50 (6.44) .8837
ACE inhibitors 423 300 (70.92) 762 542 (71.13) .9401
Statins 433 400 (92.38) 777 712 (91.63) .6492
Number of drugs at discharge, (SD) 433 6.11 (2.24) 777 5.98 (3.62) .5171
Obese, n (%) 424 190 (44.81) 761 295 (38.76) .0424*
Hypertension, n (%) 435 207 (47.59) 777 377 (48.52) .7550
Type II Diabetes, n (%) 435 94 (21.61) 777 114 (14.67) .0021**
Dyslipidemia, n (%) 434 234 (53.92) 777 434 (55.86) .5153
Psychosocial characteristics
HADS score
Depression subscale, n (%  8) 435 110 (25.29) 777 162 (20.85) .0757
Anxiety subscale, n (%  8) 435 184 (42.30) 777 301 (38.74) .2249
Major Depression 435 120 (27.59) 777 165 (21.24) .0124*
Stress
Stress at work, n (% 4) 435 210 (48.28) 777 424 (54.57) .0354*
Stress at home, n (% 4) 435 135 (31.03) 777 238 (30.63) .8838
Overall stress, n (%  4) 435 192 (44.14) 777 342 (44.02) .9671
Note.
* p < .05,
** p < .01
*** p < .001,
Ψ p < .0001.
Satisfaction with health care variables are rated on a scale from 1–4.
https://doi.org/10.1371/journal.pone.0173594.t001
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Fig 1. Forest plots of adjusted associations of sociodemographic, access to care, clinical, and psychosocial factors on study completion. a)
Adjusted for sociodemographic factors alone; b) Adjusted for sociodemographic and access to care factors; c) Adjusted for sociodemographic, access to
care, and clinical factors; d) Fully adjusted for sociodemographic, access to care, clinical, and psychosocial factors.
https://doi.org/10.1371/journal.pone.0173594.g001
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(OR = 0.66, 95% CI [0.45, 0.97]), and not having depression (OR = 1.52, 95% CI [1.11, 2.07])
were associated with greater odds of study completion.
Discussion
The GENESIS-PRAXY study enrolled 1213 patients with premature ACS. Over 12 months of
follow-up, we found that older age and higher subjective social status within one’s country at
baseline were independently associated with greater odds of study completion, whereas smok-
ing, having type II diabetes, and depression at baseline were independently associated with
lower odds of study completion.
Our age, smoking, and depression findings corroborate previous work in cardiovascular
cohorts [9–11], suggesting that study completion may occur systematically depending on these
patient characteristics. Younger individuals may feel less vulnerable to disease or less benefit
from long-term involvement in research studies [10]. Those who smoke or have depression
may be less likely to engage in health-focused interventions in general [18, 19] and lack of
study completion may be an extension of this. Additionally, smoking and depression likely put
individuals at greater risk of recurrence of coronary events. If patients in our study had a
recurrent event during our study period, then this is one possible reason for not completing
the study.
Identifying characteristics of study completion at study entry has important implications
for retention in similar studies. For instance, it may be important to refer depressed patients
for treatment when enrolling them in longitudinal case only studies. Lack of completion of
health studies in depressed patients could be due to lack of motivation. Therefore, retention
approaches specific to depressed patients may be worthwhile, e.g., collaborative care and
motivational interviewing [20]. Similarly, retention strategies might need to address possible
comorbid conditions such as type II diabetes that may prevent commitment to long-term
study participation. We know of no other study that has found that type II diabetes indepen-
dently predicts study completion in cardiovascular cohorts. However, type II diabetes was
significantly associated with lower odds of study completion in univariate analyses in one
study, though it was not significant in multivariate analyses [10]. Conversely, our results con-
tradict another study in which metabolic syndrome was independently associated with
greater odds of completion of cardiovascular community health interventions for women
[11]. The authors of that study speculated that women with high-risk characteristics (e.g.,
metabolic syndrome) may feel more motivated to willingly engage in cardiovascular health
studies in order to improve cardiovascular health. However, it may be more likely that those
with fully developed type II diabetes may feel that participating in cardiovascular health stud-
ies may not benefit them. Finally, similar to smoking and depression, having type II diabetes
may put one at greater risk of a recurrent coronary event, which in turn may influence study
completion.
This study had noteworthy strengths. First, this is the first study to assess predictors of
study completion in a cohort of premature ACS. Second, improving on the sole inclusion of
income and education, the subjective social status measures give a fuller picture of the role
socioeconomic status plays in study completion in longitudinal studies, with implications
across disciplines. Third, we included a considerable proportion of women (30%). It is difficult
to recruit young women with ACS, given that premature ACS occurs most frequently in men.
Finally, our large sample size and multicenter design suggests that our results are generalizable
across geographic regions, especially in Canada.
An important implication of our depression finding is that the association between depres-
sion and cardiovascular outcomes may be underestimated if the most depressed do not
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complete studies such as ours. Therefore, retention strategies targeting depressed individuals
may need to be developed.
A novel finding of our study was that increased subjective social status within one’s country
was independently associated with greater odds of study completion, whereas objective mea-
sures of socioeconomic status such as income, education, and working status were not. Income
is only one component of subjective social status, which may explain why income was not an
independent predictor of study attrition in our study but was previously reported to be [10].
Those with lower subjective social status tend to report less optimism, less control of life, and
more chronic stress than those of higher subjective social status [21, 22]. Together, these traits
may lead to less ability to complete longitudinal studies. Additionally, those who have lower
subjective social status may not perceive benefits to themselves or to society when participating
in health studies and therefore do not complete all phases of a longitudinal study. With impli-
cations for all participants, but especially for depressed individuals and those who perceive
their social position to be low, researchers should also work to dissipate the belief that they are
more interested in research than they are in patient’s well-being [10].
Limitations of this study
Some limitations of our study must be addressed. First, the average income in Switzerland is
much higher (median disposable income = 65,800 USD) than in Canada (median disposable
income = 36,500 USD) and the United States (median disposable income = 30,900 USD) [23],
potentially skewing our results. That is, there was only a very small portion of Swiss partici-
pants with income less than 22,500 (n = 56, 4.62%). However, using the MSSS mitigates this
limitation by assessing relative social status in addition to absolute income, which may vary
greatly. Second, incomplete data at baseline precluded using the full sample in the analyses.
This may reduce the reliability of our findings. Third, our results may not be generalizable to
other cardiovascular cohorts, i.e., they are specific to younger patients with ACS over 12
months follow-up. For instance, studies with older cardiovascular cohorts reported that greater
income, having hypertension, female sex, and having health insurance were associated with
study completion [10, 11]. However, these divergent findings may be due to methodological
differences. We examined more variables and some of the significant findings in previous
studies may have been rendered nonsignificant, had they adjusted for more factors. Third, our
analyses pertaining to ethnicity were limited to white versus non-white. In order to examine
ethnicity, we had to collapse non-white individuals into one group because of the small
numbers within each non-white ethnicity. Finally, shorter and longer term studies may have
different determinants of study completion. Our follow-up was relatively short (1 year). A car-
diovascular prevention study with a 4-year follow-up reported that lower BMI, female sex,
older age, and having health insurance were predictors of study completion, in addition to
depression [10]. Had we followed patients for a longer period of time, our results may have
mirrored theirs.
Conclusions
We identified higher subjective social status, not smoking, older age, no type II diabetes, and
no depression at baseline as independent predictors of study completion. Our results may be
used to further develop awareness and appreciation of biopsychosocial obstacles that lie in
the path to participating in longitudinal CVD studies. Knowledge of these characteristics
may be used to inform focused efforts to recruit and retain participants in future cohort
studies.
Study completion in premature acute coronary syndrome patients
PLOS ONE | https://doi.org/10.1371/journal.pone.0173594 March 16, 2017 9 / 12
Acknowledgments
The authors would like to acknowledge the contributions of Hassan Behlouli (statistical analy-
ses), Jasmine Poole (study coordination and data management) and all of the study partici-
pants. We would also like to acknowledge all of the GENESIS-PRAXY Investigators:
Co-Principal Investigators: Louise Pilote (MD, MPH, PhD), Divisions of General Internal
Medicine and Clinical Epidemiology, McGill University Health Centre, Montréal, QC, Can-
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